A 5kg newborn presents with hypoglycemia and hypotonia, with lab results showing glucose 2.2 mmol/L, fasting insulin 41 μU/mL, cortisol 551 nmol/L, and hydroxybutyrate 0.1 mmol/L. What is the most likely diagnosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Congenital Hyperinsulinism

The most likely diagnosis is A) Congenital Hyperinsulinemia. This newborn presents with the classic biochemical profile of hyperinsulinemic hypoglycemia: inappropriately elevated insulin during hypoglycemia (41 μU/mL when glucose is 2.2 mmol/L), suppressed ketones (hydroxybutyrate 0.1 mmol/L), and dramatic glucose response to treatment (rising from 2.2 to 35 mmol/L after glucose administration). 1, 2

Diagnostic Reasoning

Why Congenital Hyperinsulinism is Correct

The biochemical constellation is pathognomonic for hyperinsulinemic hypoglycemia:

  • Inappropriately elevated insulin during hypoglycemia: Insulin of 41 μU/mL (even though within "normal range" of 20-100) is completely inappropriate when glucose is 2.2 mmol/L. In true hypoglycemia, insulin should be fully suppressed to <2 μU/mL. 2, 3

  • Suppressed ketone production: Beta-hydroxybutyrate of 0.1 mmol/L (severely low, <0.6 mmol/L) indicates that insulin is blocking lipolysis and ketogenesis, which is the hallmark of hyperinsulinism. 2, 3

  • Dramatic glucose response: The rise from 2.2 to 35 mmol/L after glucose administration demonstrates that the hypoglycemia is due to excessive glucose consumption driven by insulin, not impaired glucose production. 1

  • Congenital hyperinsulinism is the most common cause of persistent hypoglycemia in neonates, representing dysregulated insulin secretion that fails to suppress appropriately during hypoglycemia. 1, 3, 4

Why Other Options are Incorrect

B) Glycogen Storage Disease (GSD):

  • GSD would present with appropriately suppressed insulin during hypoglycemia (insulin <2 μU/mL), not elevated insulin. 2
  • GSD typically shows elevated lactate and uric acid, which are not mentioned here. 2
  • The dramatic glucose response argues against impaired glucose production mechanisms.

C) Adrenal Insufficiency:

  • The cortisol level is 551 nmol/L, which is elevated/high, not low. [@question context@]
  • Adrenal insufficiency would show low cortisol (<138 nmol/L in stress situations).
  • The presence of elevated insulin with suppressed ketones cannot be explained by adrenal insufficiency alone.

D) Growth Hormone Deficiency:

  • While GH deficiency can cause hypoglycemia, it would not produce inappropriately elevated insulin or suppressed ketones to this degree.
  • The biochemical profile is inconsistent with isolated GH deficiency.

Clinical Implications and Next Steps

Immediate Management

  • Maintain plasma glucose >3.9 mmol/L (70 mg/dL) to prevent brain damage from recurrent hypoglycemia. 3, 4
  • Frequent glucose monitoring is essential, as hypoglycemia can cause seizures, developmental delay, and permanent brain damage. 3, 5

Diagnostic Workup Required

  • Immediate genetic testing should be pursued for KATP channel mutations (KCNJ11, ABCC8), which are the most common causes of congenital hyperinsulinism. 1, 2
  • Consider HNF4A-MODY testing, as this can present with transient neonatal hypoglycemia and large birth weight (though the 5 kg weight is not specified as large-for-gestational-age). 2
  • Genetic testing is critical because some forms (KATP-related) may respond to sulfonylureas, while others require different management strategies. 1

Treatment Considerations

  • Diazoxide is the first-line medical therapy for most forms of congenital hyperinsulinism. 6
  • If diazoxide-unresponsive, options include octreotide, glucagon, or surgical intervention depending on focal vs. diffuse disease. 4, 6
  • Advanced radiologic imaging (PET scan) may be needed to identify focal lesions that are surgically curable. 4

Critical Pitfalls to Avoid

  • Do not be misled by insulin levels within the "normal range": Any detectable insulin (>2 μU/mL) during hypoglycemia is inappropriate and diagnostic of hyperinsulinism. 2, 3
  • Do not delay treatment: Recurrent hypoglycemia in the neonatal period can cause irreversible neurodevelopmental disabilities, epilepsy, and cerebral palsy. 5, 4
  • Do not assume transient hypoglycemia: This requires immediate genetic workup as it represents a permanent form requiring specific diagnosis and long-term management. 1

References

Guideline

Congenital Hyperinsulinism Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis and Management of Neonatal Monogenic Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.